Contact us for free information or to start a free case review.
Purdue Pharma’s popular and controversial prescription drug OxyContin has avoided being named in a certification of a class action lawsuit claiming harm, including addiction.
OxyContin contains a very strong narcotic pain reliever similar to morphine that has been linked to more than 100 deaths and has the FDA’s strongest warning label, saying the drug is as potentially addictive as morphine. A New York Supreme Court Judge denied the plaintiffs’ motion for certification of a personal injury lawsuit after ruling the plaintiffs had failed to meet the “commonality requirement” of class certification, which would be inappropriate for the important individual issues to be lumped together.
OxyContin tablets provide 12 hours of pain relief when swallowed whole, but the drug is now the leading prescription medication diverted to illegal use in the nation. If chewed, snorted or injected, OxyContin can produce a quick and potentially deadly high. The use as a recreational drug in recent years prompted the FDA to strengthen the warning labeling, and pharmacies have increased security against employee and patron theft.
Class certification in OxyContin related litigation has now been denied in written opinions on nine occasions in state and federal courts. Over recent years, parent Web sites warning of the dangers of OxyContin abuse have been springing up in response to lost loved ones that died from OxyContin overdoses or deadly interactions. Like any opioid, OxyContin is easy to get addicted to and hard to get off.
Copyright © 2001 - 2012 Online Lawyer Source
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.